9:41
toxys.com
Screenshot of toxys.com
toxys.com favicon

toxys.com

25 technologies
VerifiedVisit1.3K/mo$7M4325 Tech6 Leads
Deep Dive

Toxys: The Quiet Giant in Predictive Toxicology

A 43-person Dutch biotech disrupting animal testing with mechanistic NAMs

Toxys isn't just another contract research organization—they're building the definitive playbook for non-animal safety testing. While the industry debates the future, they've already shipped proprietary assays like ToxTracker and ReproTracker that pharmaceutical giants rely on.

$6.7M
annual revenue
43
employees
1,309
monthly visits
42%
organic search traffic

"They're not selling services—they're selling the science of replacement. Every assay they develop makes animal testing a little more obsolete."

The Mechanistic Edge

Toxys dominates three critical niches: genotoxicity (ToxTracker), developmental toxicity (ReproTracker), and comet assays. Their 80 monthly searches for 'toxtracker' and 'crossdart' reveal a focused, high-intent audience—regulatory scientists who know exactly what they need and search by assay name, not generic terms.

The Traffic Paradox

With only 1,309 monthly visits, Toxys operates in stealth mode. But that's the point: their customers are PhDs and regulatory affairs directors, not casual browsers. The 36% direct traffic indicates a captive audience who bookmarks their login page. They don't need mass awareness—they need the right 1,300 visitors.

The Dutch biotech's 100% 'undefined' traffic share (likely Netherlands + EU) suggests they're dominating their home turf before scaling globally. Their US contact email ([email protected]) signals a deliberate transatlantic expansion, but they're still in the early innings of that playbook.

  • Proprietary assay IP (ToxTracker, ReproTracker) creates defensible moat
  • 43-person team suggests efficient R&D leverage—likely <10 scientists driving core innovation
  • 260 monthly searches for 'reprotracker' indicates growing market validation
  • Netherlands base gives them EU regulatory credibility ahead of US competitors
No public funding announcements (rare for biotech)
Proprietary NAMs with published validation
Minimal web presence (1,309 visits/month)
Dual presence in EU and US markets
No Trustpilot reviews or public customer testimonials
Focus on high-value mechanistic endpoints

The Sleeping Beauty of In Vitro Toxicology

Toxys proves you don't need massive traffic or VC funding to build category-defining science. Their moat isn't marketing—it's data. Every assay they run generates proprietary validation data that becomes harder to replicate. In a field where trust is everything, they've built it quietly, one mechanistic endpoint at a time.

What tech stack does Toxys use?

31 detected
Security1
Programming Languages1
Privacy & Consent1
Email Marketing1
Customer Support1
Performance1
Web Standards2
UI Libraries1
Tracking & Analytics6
G
Google Tag Manager
G
Google APIs
G
Google Static
G
Google Tag Manager
G
Google Analytics
G
Google DoubleClick

How much traffic does Toxys get?

Traffic & Engagement

1.3K
Monthly Visits
1.4
Pages/Visit
0:11
Avg. Duration
34%
Bounce Rate
Monthly Traffic Trend-71%
4.6K
Oct 2025
Oct
1.4K
Nov 2025
Nov
1.3K
Dec 2025
Dec

Traffic Sources

Search
42%
Direct
36%
Social
4%
Referrals
16%
Email
0%
Paid
1%

Where is Toxys's audience located?

🌍100.0%

What keywords does Toxys rank for?

5 keywords
1crossdart80 vol
2toxtracker80 vol
3reprotracker260 vol
4comet assay1.8K vol$4.01
5genotoxic960 vol

How is Toxys's SEO?

Open Graph Image

OG Image preview
og:image

https://toxys.com/wp-content/uploads/2025/01/in-vitro-assay-microscopy-1024x683.png

Meta Tags

title27 chars

In Vitro Toxicology - Toxys

description140 chars

In vitro toxicology services provided by Toxys using unique NAMs on genotoxicity, DART, and mechanistic assessments from Netherlands and USA

languageEN-US

H1 Tags

h1Experts in mechanistic toxicity testing
h1Toxys in 90 seconds
h1Happy Customers

Schema Types

Unknown

Who works at Toxys?

Loading leads...

What do customers think of Toxys?

No Trustpilot reviews available for this company.

Frequently Asked Questions about Toxys

What is Toxys's Revenue?
Toxys generates approximately $7M in annual revenue. With 43 employees, that's $155,000 per employee.
What does Toxys do?
In vitro toxicology services provided by Toxys using unique NAMs on genotoxicity, DART, and mechanistic assessments from Netherlands and USA
How fast is Toxys growing?
Toxys employee count has changed by 10% year over year.
What technologies does Toxys use?
Toxys uses 25 technologies across their website including Maps, Fonts, Security. Key technologies include Google Maps, Font Awesome, Google Fonts, reCAPTCHA.
Who are Toxys's competitors?
Toxys's main competitors include Dermavant Sciences, Metrum Research Group, Clovis Oncology, ArcherDX, Inscripta. These companies operate in similar markets and compete for the same customer base.

Export Data

Unlock all exports

Download CSVs, JSONs & full reports

How to contact Toxys?

What are Toxys's key pages?

Export toxys.com Data

Download the complete tech stack, analytics, leads, and company data for toxys.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.

Raw JSON Data

Click "Show" to view the raw API response data

About toxys.com

In vitro toxicology services provided by Toxys using unique NAMs on genotoxicity, DART, and mechanistic assessments from Netherlands and USA

Company Overview

toxys.com
Website
#12,180,247
Global Rank
1.3K
Monthly Visitors
25
Technologies
6+
Employees

toxys.com Social Media

Contact toxys.com

Technology Stack

toxys.com uses 25 technologies across their website including Google Maps, Font Awesome, Google Fonts, reCAPTCHA, and more.

Maps

Google Maps

Fonts

Font Awesome, Google Fonts

Security

reCAPTCHA

Programming Languages

PHP

CMS

WordPress

Cloud & Hosting

Amazon S3, Amazon Web Services

Traffic & Audience

1.3K
Monthly Visits
34%
Bounce Rate
1.4
Pages/Visit
0:11
Avg. Duration

toxys.com receives approximately 1.3K monthly visitors and ranks #12,180,247 globally. The website has a bounce rate of 34% with visitors viewing an average of 1.4 pages per visit. Users spend an average of 0:11 on the site.

The majority of toxys.com's traffic comes from .

Frequently Asked Questions

What is toxys.com?
In vitro toxicology services provided by Toxys using unique NAMs on genotoxicity, DART, and mechanistic assessments from Netherlands and USA
What technologies does toxys.com use?
toxys.com uses 25 technologies including Google Maps, Font Awesome, Google Fonts, and 19 more. View the full tech stack analysis above.
How do I contact toxys.com?
You can contact toxys.com via email at [email protected] or through their contact page.
What are toxys.com's social media accounts?
toxys.com is active on youtube. You can find links to all their social media profiles in the social section above.
How popular is toxys.com?
toxys.com receives approximately 1.3K monthly visitors and ranks #12,180,247 globally. Traffic is declining by 4.6% month-over-month.

Related Searches

toxys.com pricingtoxys.com reviewstoxys.com alternativestoxys.com logintoxys.com careerswhat is toxys.comtoxys.com tech stacktoxys.com contacttoxys.com vs competitorstoxys.com featureshow to use toxys.comtoxys.com integrations

This page provides publicly available information about toxys.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit toxys.com directly at https://toxys.com.